Jan Aarseth

3.0k total citations
66 papers, 2.1k citations indexed

About

Jan Aarseth is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Jan Aarseth has authored 66 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 24 papers in Neurology and 11 papers in Immunology. Recurrent topics in Jan Aarseth's work include Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (17 papers) and Polyomavirus and related diseases (9 papers). Jan Aarseth is often cited by papers focused on Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (17 papers) and Polyomavirus and related diseases (9 papers). Jan Aarseth collaborates with scholars based in Norway, United States and Denmark. Jan Aarseth's co-authors include Kjell‐Morten Myhr, Nina Grytten, K-M Myhr, Christian A. Vedeler, Harald Nyland, Rune Midgard, Halvor Næss, Lars Thomassen, Sissel E. Monstad and A. G. Beiske and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Jan Aarseth

65 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Aarseth Norway 27 1.1k 559 289 260 235 66 2.1k
Edgardo Cristiano Argentina 23 1.1k 1.0× 486 0.9× 200 0.7× 211 0.8× 226 1.0× 116 1.7k
Bahia Hakiki Italy 25 1.5k 1.3× 712 1.3× 281 1.0× 112 0.4× 170 0.7× 75 2.1k
Mario Habek Croatia 26 1.2k 1.0× 872 1.6× 132 0.5× 153 0.6× 155 0.7× 215 2.4k
Barbara S. Giesser United States 25 1.5k 1.3× 340 0.6× 192 0.7× 586 2.3× 295 1.3× 46 2.7k
Giovanni Frisullo Italy 28 648 0.6× 574 1.0× 375 1.3× 501 1.9× 98 0.4× 104 2.3k
Chiara Zecca Switzerland 24 1.4k 1.2× 736 1.3× 182 0.6× 174 0.7× 389 1.7× 129 2.7k
A. Reggio Italy 32 1.2k 1.1× 943 1.7× 220 0.8× 265 1.0× 567 2.4× 81 2.9k
Jan Boringa Netherlands 12 1.6k 1.4× 464 0.8× 104 0.4× 268 1.0× 198 0.8× 15 2.3k
F Munschauer United States 18 1.9k 1.6× 564 1.0× 128 0.4× 161 0.6× 223 0.9× 20 2.4k
David I. Kaufman United States 26 1.2k 1.0× 976 1.7× 327 1.1× 132 0.5× 175 0.7× 61 2.9k

Countries citing papers authored by Jan Aarseth

Since Specialization
Citations

This map shows the geographic impact of Jan Aarseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Aarseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Aarseth more than expected).

Fields of papers citing papers by Jan Aarseth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Aarseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Aarseth. The network helps show where Jan Aarseth may publish in the future.

Co-authorship network of co-authors of Jan Aarseth

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Aarseth. A scholar is included among the top collaborators of Jan Aarseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Aarseth. Jan Aarseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fossum, Magdalena, Jan Aarseth, Stig Wergeland, et al.. (2025). Early extended interval dosing of rituximab in multiple sclerosis: A comparative cohort study on efficacy and safety. Multiple Sclerosis and Related Disorders. 97. 106400–106400. 2 indexed citations
2.
Torkildsen, Øivind, Jan Aarseth, Marianna Cortese, et al.. (2024). Migraine in the multiple sclerosis prodrome: a prospective nationwide cohort study in pregnant women. The Journal of Headache and Pain. 25(1). 225–225. 1 indexed citations
3.
Torkildsen, Øivind, Jan Aarseth, Elisabeth Gulowsen Celius, et al.. (2022). Association of adverse childhood experiences with the development of multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 93(6). 645–650. 13 indexed citations
4.
Torkildsen, Øivind, Jan Aarseth, Heidi Øyen Flemmen, et al.. (2021). Perinatal Depression and Anxiety in Women With Multiple Sclerosis. Neurology. 96(23). e2789–e2800. 22 indexed citations
5.
Grytten, Nina, Kjell‐Morten Myhr, Elisabeth Gulowsen Celius, et al.. (2021). Incidence of cancer in multiple sclerosis before and after the treatment era– a registry- based cohort study. Multiple Sclerosis and Related Disorders. 55. 103209–103209. 19 indexed citations
6.
Harbo, Hanne F., et al.. (2016). Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood. BMC Genetics. 17(1). 59–59. 15 indexed citations
7.
Grytten, Nina, et al.. (2015). A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway. Journal of Neurology Neurosurgery & Psychiatry. 87(1). jnnp–2014. 50 indexed citations
8.
Gustavsen, Marte W., Marte K. Viken, Elisabeth Gulowsen Celius, et al.. (2014). Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general. Journal of Neuroimmunology. 274(1-2). 174–179. 6 indexed citations
9.
Telstad, Wenche, et al.. (2014). Employment among Patients with Multiple Sclerosis-A Population Study. PLoS ONE. 9(7). e103317–e103317. 83 indexed citations
10.
Storstein, Anette, et al.. (2010). Onconeural antibodies: Improved detection and clinical correlations. Journal of Neuroimmunology. 232(1-2). 166–170. 27 indexed citations
11.
Lorentzen, Åslaug Rudjord, Espen Melum, Eva Ellinghaus, et al.. (2010). Association to the Glypican-5 gene in multiple sclerosis. Journal of Neuroimmunology. 226(1-2). 194–197. 19 indexed citations
12.
Myhr, K.‐M., et al.. (2010). The cost of multiple sclerosis in Norway. The European Journal of Health Economics. 13(1). 81–91. 25 indexed citations
13.
Aarseth, Jan, et al.. (2009). Interleukin-10 promoter polymorphisms in myasthenia gravis. Journal of Neuroimmunology. 210(1-2). 63–66. 17 indexed citations
14.
Haugen, Mette, et al.. (2008). Proteasome Antibodies in Patients with Cancer or Multiple Sclerosis. Scandinavian Journal of Immunology. 67(4). 400–403. 5 indexed citations
15.
Aarseth, Jan, et al.. (2007). Hu and Yo antibodies have heterogeneous avidity. Journal of Neuroimmunology. 185(1-2). 162–167. 4 indexed citations
16.
Monstad, Sissel E., Anne Dørum, Per Eystein Lønning, et al.. (2006). Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique. Cancer Immunology Immunotherapy. 55(10). 1280–1284. 20 indexed citations
17.
Næss, Halvor, Harald Nyland, Lars Thomassen, Jan Aarseth, & Kjell‐Morten Myhr. (2005). Fatigue at Long-Term Follow-Up in Young Adults with Cerebral Infarction. Cerebrovascular Diseases. 20(4). 245–250. 119 indexed citations
18.
Thomassen, Lars, Ulrike Waje‐Andreassen, Halvor Næss, Jan Aarseth, & David Russell. (2005). Combined Carotid and Transcranial Ultrasound Findings Compared with Clinical Classification and Stroke Severity in Acute Ischemic Stroke. Cerebrovascular Diseases. 21(1-2). 86–90. 4 indexed citations
19.
Gavasso, Sonia, Ottar Nygård, Eva Ringdal Pedersen, et al.. (2005). Fcγ receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 180(2). 277–282. 27 indexed citations
20.
Myhr, Kjell‐Morten, et al.. (2002). Interleukin-10 promoter polymorphisms in patients with multiple sclerosis. Journal of the Neurological Sciences. 202(1-2). 93–97. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edgardo Cristiano Breakdown of academic impact, for papers by Bahia Hakiki Breakdown of academic impact, for papers by Mario Habek Breakdown of academic impact, for papers by Barbara S. Giesser Breakdown of academic impact, for papers by Giovanni Frisullo Breakdown of academic impact, for papers by Chiara Zecca Breakdown of academic impact, for papers by A. Reggio Breakdown of academic impact, for papers by Jan Boringa Breakdown of academic impact, for papers by F Munschauer Breakdown of academic impact, for papers by David I. Kaufman
Rankless by CCL
2026